Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-14-367924
Filing Date
2014-10-09
Accepted
2014-10-09 17:09:37
Documents
7
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A d791123d10qa.htm 10-Q/A 20214
  Complete submission text file 0001193125-14-367924.txt   3513259

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT ck0001478069-20140630.xml EX-101.INS 506690
3 XBRL TAXONOMY EXTENSION SCHEMA ck0001478069-20140630.xsd EX-101.SCH 46646
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001478069-20140630_cal.xml EX-101.CAL 53285
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001478069-20140630_def.xml EX-101.DEF 162987
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001478069-20140630_lab.xml EX-101.LAB 345552
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001478069-20140630_pre.xml EX-101.PRE 253911
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36577 | Film No.: 141150661
SIC: 2834 Pharmaceutical Preparations